AllAbstractsNews & PressPresentationsPublications Read More cTAP Publishes Comprehensive Analysis of NSAA September 26, 2019 Read More Categorising trajectories and individual item changes of the NSAA in patients with DMD September 3, 2019 Read More 2019 EAN Abstract - Phase 1b/2 Study of RG6206 September 1, 2019 Read More 2019 EU ISPOR Abstract - NSAA consistency analysis June 12, 2019 Read More 2019 EU ISPOR Abstract - Prognostic Model for Loss of Walking in DMD June 5, 2019 Read More 2019 MDA Abstract - NSAA Shift Analyses April 13, 2019 Read More 2019 MDA Abstract - The Collaborative Trajectory Analysis Project (cTAP) April 13, 2019 Read More 2019 PTC WMS Abstract - Steroid Use and DMD April 3, 2019 Read More 2019 WMS Abstract - Prognostic score for loss of walking ability in DMD April 2, 2019 Read More 2019 WMS Abstract - 48-Week Changes in NSAA April 2, 2019 Read More 2019 WMS Abstract - Lean Body Mass and Motor Function in DMD Patients April 2, 2019 Read More 2019 WMS Abstract - Estimating Changes in NSAA and 4SC in DMD April 2, 2019 Read More 2019 Myology Abstract - Changes in 4SC over Two Years in DMD March 25, 2019 Read More cTAP Partner Wins ISPOR Award on Duchenne Muscular Dystrophy December 5, 2018 Read More 2018 ISPOR EU Abstract - Ambulatory Function in Duchenne Muscular Dystrophy October 17, 2018 Read More Moneyball Medicine: Thriving in the new data-driven healthcare market October 17, 2018 Read More 2018 Action Duchenne abstract - Longitudinal analyses of 4SC velocity in Leuven October 17, 2018 Read More WMS 2018 Abstract - Consistency of 6MWD October 3, 2018 Read More WMS 2018 Abstract - Minimal detectable change in NSAA October 3, 2018 Read More WMS 2018 Abstract - 4SC Velocity Prognostic Model October 2, 2018 Read More cTAP to Present Late-breaking Results at the World Muscle Society Congress October 1, 2018 Read More 2018 Action Duchenne abstract - Consistency of 1-year change in 6MWD August 31, 2018 Read More Action Duchenne International Conference 2018 Abstract - Phase 1b/2 study of the anti-myostatin adnectin RG6206 August 29, 2018 Read More 2018 Action Duchenne abstract - MCID of 4SC and NSAA in CCHMC August 27, 2018 Read More 2018 ICNMD - 4SC prognostic model July 18, 2018 Read More cTAP to Present at Annual Biopharmaceutical Conference June 25, 2018 Read More 2017 WMS Abstract - Validation of a prognostic score for changes in 6MWD October 3, 2017 Read More 2017 WMS Abstract - The Collaborative Trajectory Analysis Collaboration October 3, 2017 Read More 2017 WMS Abstract - Consistency between natural history and clinical trial placebo October 3, 2017 Read More 2017 WMS Abstract - Clustering Trajectories of Ambulatory Function October 3, 2017 Read More Summit Therapeutics Joins cTAP to Support the Development of Potential DMD Treatments September 29, 2017 Read More R&D Partnerships April 1, 2017 Read More Modern Solutions to Recurring Roadblocks in Clinical Testing March 6, 2017 Read More Marathon Pharmaceuticals and Italfarmaco Join cTAP February 7, 2017 Read More 2017 IRDiRC Abstract - Translating Natural History into Clinical Trial Design February 3, 2017 Read More Eli Lilly and Company Joins cTAP December 21, 2016 Read More Nontraditional Approaches to Big Data Analyses: A Case Study in Rare Disease December 1, 2016 Read More cTAP Announces Two Research Publications October 31, 2016 Read More Non-Profits, Pharmaceutical Companies and Noted Clinicians Collaborate to Launch cTAP October 25, 2016 Read More Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy October 13, 2016 Read More Supplemental Materials on Neuromuscular Disorders September 1, 2016 Read More Categorizing natural history trajectories of ambulatory function May 24, 2016
AllAbstractsNews & PressPresentationsPublications Read More cTAP Publishes Comprehensive Analysis of NSAA September 26, 2019 Read More Categorising trajectories and individual item changes of the NSAA in patients with DMD September 3, 2019 Read More 2019 EAN Abstract - Phase 1b/2 Study of RG6206 September 1, 2019 Read More 2019 EU ISPOR Abstract - NSAA consistency analysis June 12, 2019 Read More 2019 EU ISPOR Abstract - Prognostic Model for Loss of Walking in DMD June 5, 2019 Read More 2019 MDA Abstract - NSAA Shift Analyses April 13, 2019 Read More 2019 MDA Abstract - The Collaborative Trajectory Analysis Project (cTAP) April 13, 2019 Read More 2019 PTC WMS Abstract - Steroid Use and DMD April 3, 2019 Read More 2019 WMS Abstract - Prognostic score for loss of walking ability in DMD April 2, 2019 Read More 2019 WMS Abstract - 48-Week Changes in NSAA April 2, 2019 Read More 2019 WMS Abstract - Lean Body Mass and Motor Function in DMD Patients April 2, 2019 Read More 2019 WMS Abstract - Estimating Changes in NSAA and 4SC in DMD April 2, 2019 Read More 2019 Myology Abstract - Changes in 4SC over Two Years in DMD March 25, 2019 Read More cTAP Partner Wins ISPOR Award on Duchenne Muscular Dystrophy December 5, 2018 Read More 2018 ISPOR EU Abstract - Ambulatory Function in Duchenne Muscular Dystrophy October 17, 2018 Read More Moneyball Medicine: Thriving in the new data-driven healthcare market October 17, 2018 Read More 2018 Action Duchenne abstract - Longitudinal analyses of 4SC velocity in Leuven October 17, 2018 Read More WMS 2018 Abstract - Consistency of 6MWD October 3, 2018 Read More WMS 2018 Abstract - Minimal detectable change in NSAA October 3, 2018 Read More WMS 2018 Abstract - 4SC Velocity Prognostic Model October 2, 2018 Read More cTAP to Present Late-breaking Results at the World Muscle Society Congress October 1, 2018 Read More 2018 Action Duchenne abstract - Consistency of 1-year change in 6MWD August 31, 2018 Read More Action Duchenne International Conference 2018 Abstract - Phase 1b/2 study of the anti-myostatin adnectin RG6206 August 29, 2018 Read More 2018 Action Duchenne abstract - MCID of 4SC and NSAA in CCHMC August 27, 2018 Read More 2018 ICNMD - 4SC prognostic model July 18, 2018 Read More cTAP to Present at Annual Biopharmaceutical Conference June 25, 2018 Read More 2017 WMS Abstract - Validation of a prognostic score for changes in 6MWD October 3, 2017 Read More 2017 WMS Abstract - The Collaborative Trajectory Analysis Collaboration October 3, 2017 Read More 2017 WMS Abstract - Consistency between natural history and clinical trial placebo October 3, 2017 Read More 2017 WMS Abstract - Clustering Trajectories of Ambulatory Function October 3, 2017 Read More Summit Therapeutics Joins cTAP to Support the Development of Potential DMD Treatments September 29, 2017 Read More R&D Partnerships April 1, 2017 Read More Modern Solutions to Recurring Roadblocks in Clinical Testing March 6, 2017 Read More Marathon Pharmaceuticals and Italfarmaco Join cTAP February 7, 2017 Read More 2017 IRDiRC Abstract - Translating Natural History into Clinical Trial Design February 3, 2017 Read More Eli Lilly and Company Joins cTAP December 21, 2016 Read More Nontraditional Approaches to Big Data Analyses: A Case Study in Rare Disease December 1, 2016 Read More cTAP Announces Two Research Publications October 31, 2016 Read More Non-Profits, Pharmaceutical Companies and Noted Clinicians Collaborate to Launch cTAP October 25, 2016 Read More Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy October 13, 2016 Read More Supplemental Materials on Neuromuscular Disorders September 1, 2016 Read More Categorizing natural history trajectories of ambulatory function May 24, 2016
